Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Exploring the risk factors for perineal wound infection after laparoscopic abdominoperineal resection.

Annals of medicine and surgery (2012)·2026

Same author

Efficacy and patient satisfaction with Sayana Press (DMPA- SC) among women seeking birth spacing.

JPMA. The Journal of the Pakistan Medical Association·2026

Same author

Assessment of Local Recurrence and Distant Metastasis After Curative Resection of Rectal Tumors: A Retrospective Study.

Cureus·2026

Same author

Fertility-Sparing Surgery for Ovarian Mucinous Tumors and Risk of Recurrence.

Cureus·2026

Same author

Domestic violence in pregnancy.

JPMA. The Journal of the Pakistan Medical Association·2026

Same author

The textbook outcome of pancreaticoduodenectomy for adenocarcinoma of the pancreas in a high-volume centre.

Surgery in practice and science·2026

Search research articles

Related Experiment Video

Updated: May 2, 2026

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Published on: January 22, 2022

Laparoscopic Versus Open Surgery for Advanced-Stage Ovarian Cancer: A 10-Year Data Analysis.

Kheyal Khalil¹, Maria Habib², Anam Riaz¹

¹Surgical Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, PAK.

|May 1, 2026

Summary

Laparoscopic surgery for advanced ovarian cancer shows shorter hospital stays and less blood loss but no significant survival advantage over open surgery. Both methods offer comparable long-term outcomes for patients.

Keywords:

advanced ovarian cancer gynecological cancers laparoscopic surgery minimally invasive surgery ovarian cancer surgery

More Related Videos

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Published on: April 11, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Related Experiment Videos

Last Updated: May 2, 2026

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Published on: January 22, 2022

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Published on: April 11, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Area of Science:

Gynecologic Oncology
Surgical Oncology
Minimally Invasive Surgery

Background:

Advanced-stage ovarian cancer (Stage III/IV) presents significant treatment challenges.
Surgical intervention is a cornerstone of treatment for ovarian cancer.
Laparoscopic and open surgical approaches are utilized for cytoreductive surgery.

Purpose of the Study:

To compare short-term surgical outcomes and long-term survival (progression-free survival and overall survival) between laparoscopic and open surgery for advanced ovarian cancer.
To evaluate intraoperative and postoperative indicators in patients undergoing these surgical modalities.
To determine if surgical approach impacts patient survival in advanced ovarian cancer.

Main Methods:

Retrospective cohort study of 171 patients with advanced ovarian cancer (Stage III/IV) from January 2014 to January 2024.
Data collected included patient characteristics, surgical approach (laparoscopic vs. open), and neoadjuvant chemotherapy.
Surgical outcomes, progression-free survival (PFS), and overall survival were compared between the two groups.

Main Results:

Laparoscopic surgery was associated with significantly less average blood loss (82 mL vs. 164 mL) and shorter hospital stays (3.24 days vs. open surgery).
Laparoscopic surgery had a longer average operative time (231 minutes vs. open surgery).
While open surgery showed slightly longer overall and PFS, the differences were not statistically significant compared to laparoscopic surgery.

Conclusions:

Laparoscopic surgery offers short-term benefits for advanced ovarian cancer, including reduced intraoperative blood loss and shorter hospital stays.
No significant difference in overall survival or progression-free survival was observed between laparoscopic and open surgery in this cohort.
The choice between laparoscopic and open surgery for advanced ovarian cancer may depend on balancing short-term surgical advantages with comparable long-term oncologic outcomes.